Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 27.19 | -32.75 |
PEG Ratio (TTM) | 0.82 | -2.62 |
P/S Ratio (TTM) | N/A | 35.22 |
P/B Ratio (TTM) | 1.31 | 6.92 |
P/FCF Ratio (TTM) | -519.24 | -188.65 |
Price to 5YR AVG Earnings Ratio | N/A | -29.46 |
Price to 5YR AVG FCF Ratio | N/A | -26.95 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.59% | 47.25% |
ROE (TTM) | 4.89% | -531.49% |
Net Profit Margin (TTM) | N/A | -264.51% |
ROIC 5YR AVG | N/A | 831.75% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 11,526.05% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 11,831.03% | N/A | N/A |
Cash Flow | -39.72% | N/A | N/A |
Health (53%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 7.74 | 4.81 |
Quick Ratio (TTM) | 7.74 | 24.14 |
D/E Ratio (TTM) | 0.01 | 0.23 |
Interest Coverage (TTM) | N/A | 2.74 |
Piotroski F-Score | N/A | 3 |
Altman Z-Score | 16.91 | 21.22 |
LTL to 5YR AVG FCF | N/A | -1.27 |
Shares Outstanding Growth 5YR AVG | N/A | 515.61% |